The next generation of treatments for shock or stroke could be based on a protein that is already in our heads – neuroglobin. In a review article to be published in the November issue of The FASEB Journal, scientists from University of Rome describe this protein, which may be the key to unlocking new therapies to minimize brain damage and improve recoveries for patients.